Figure 1.

The drug development sequence. Note that the drug sponsor accumulates large amounts of data about the drug, and has eliminated the least promising agents before the design process for randomized controlled trials occurs.

Fries and Krishnan Arthritis Res Ther 2004 6:R250-R255   doi:10.1186/ar1170
Download authors' original image